title: Nitric oxide synthase regulation during embryonic implantation.
abstract: It has previously been demonstrated that uterine nitric oxide synthase (NOS) activity increases before embryonic implantation in rats. The aim of the present work was to investigate the regulation and the physiological relevance of the nitric oxide (NO) system in ovoimplantation. The increase in NOS activity in early pregnancy was found to be independent of the presence of embryos in the uterus. Whereas the Ca2+-dependent isoform of NOS increased gradually in the preimplantation days, the Ca2+-independent isoform increased just at the beginning of implantation (Day 5, 1800 hours); then the activity of both isoforms declined. Oestradiol, whose concentration peaks before implantation, might be regulating NOS activity in the uterus, since treatment of rats with tamoxifen, a receptor antagonist, reduces the activity of both isoforms to preimplantation levels. Intraluminal injections of L-NAME (0.5 mg kg[-1]), a competitive inhibitor of NOS, reduced by 50% the number of implanted embryos; this suggests that the NO system plays a role during implantation. The data suggest that oestradiol might be a modulator of NOS activity during nidation and that NO production is necessary to achieve a successful embryo implantation.
authors.affiliation: Centro de Estudios Farmacológicos y Botánicos, CONICET, Buenos Aires, Argentina.
authors.forename: V
authors.initials: V
authors.lastname: Novaro
authors.forename: E
authors.initials: E
authors.lastname: González
authors.forename: A
authors.initials: A
authors.lastname: Jawerbaum
authors.forename: V
authors.initials: V
authors.lastname: Rettori
authors.forename: G
authors.initials: G
authors.lastname: Canteros
authors.forename: M F
authors.initials: MF
authors.lastname: Gimeno
mesh_terms: D000818:Animals; D002118:Calcium / Q000494:pharmacology; D010064:Embryo Implantation / Q000187:drug effects / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004965:Estrogen Antagonists / Q000494:pharmacology; D005260:Female; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D011247:Pregnancy; D051381:Rats; D017208:Rats, Wistar; D013629:Tamoxifen / Q000494:pharmacology; D013997:Time Factors; D014599:Uterus / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology
chemical_list: D004791:Enzyme Inhibitors; D004965:Estrogen Antagonists; D007527:Isoenzymes; D013629:Tamoxifen; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase; D002118:Calcium; D019331:NG-Nitroarginine Methyl Ester